TWOJE ZAMÓWIENIE
Twój koszyk jest pusty
Zacznij dodawać peptydy badawcze do koszyka.
MOŻE CI SIĘ SPODOBAĆ
Twój koszyk jest pusty
Zacznij dodawać peptydy badawcze do koszyka.
MOŻE CI SIĘ SPODOBAĆ
A long-acting GLP-1 receptor agonist peptide used in metabolic research, with a modified structure that extends its half-life to approximately one week.
Semaglutide is a synthetic analogue of human glucagon-like peptide-1 (GLP-1) with 94% amino acid sequence homology to native GLP-1, engineered with key modifications that extend its half-life to approximately 7 days, enabling once-weekly dosing. These modifications include an amino acid substitution at position 8 (Aib for Ala) to resist DPP-4 degradation, and acylation with a C18 fatty diacid chain at position 26 to promote albumin binding and slow renal clearance. Semaglutide activates the GLP-1 receptor to enhance glucose-dependent insulin secretion, suppress glucagon, delay gastric emptying, and reduce appetite through central nervous system satiety pathways. While effective as a single-mechanism GLP-1 agonist, research has shown that dual-agonist approaches like tirzepatide (GIP/GLP-1) may produce superior outcomes in body weight reduction. Semaglutide remains one of the most significant peptide therapeutics developed in metabolic research.
Glucagon-Like Peptide-1, an incretin hormone that regulates blood sugar, slows gastric emptying, and reduces appetite, targeted by semaglutide and tirzepatide.
A first-in-class dual GIP/GLP-1 receptor agonist peptide with superior metabolic efficacy, acting on both incretin pathways simultaneously.
Glucose-dependent Insulinotropic Polypeptide receptor, a key target in metabolic peptide research that mediates insulin secretion and energy homeostasis.
The time required for the concentration of a substance in the body to decrease by 50%, a key pharmacokinetic parameter determining dosing frequency.
The fundamental building blocks of peptides and proteins, with 20 standard types that combine in unique sequences to create biologically active molecules.
Body Protection Compound-157, a synthetic 15-amino acid peptide derived from human gastric juice with potent tissue-healing and neuroprotective properties.
Legal under MHRA rules. BPC-157, tirzepatide & NAD+ pens with next-day UK delivery from £99. >99% purity, GMP certified. Shop now.
ARTICLEPens cut dosing error from 15% to under 2%. We compare accuracy, contamination risk, cost, and convenience. See why researchers are switching in 2026.
ARTICLEOver 100 published studies back BPC-157 for tissue repair, gut healing, and neuroprotection. Mechanisms, dosing protocols, and where to buy in the UK.
COMPARISONCompare BPC-157 and TB-500 for recovery research. Mechanisms, benefits, dosing, and when to use each peptide. Buy both as pre-mixed pens UK.
COMPARISONCompare tirzepatide and semaglutide for metabolic research. Dual vs single receptor, efficacy data, side effects, and pricing. Buy tirzepatide pens UK.
ENCYCLOPEDIAGastric Pentadecapeptide. Molecular weight: 1419.53 Da. Explore mechanism of action, key studies, and research applications.
BUNDLEThe most studied peptide duo in tissue regeneration research
PROTOCOLResearch protocol combining BPC-157 and TB-500 peptide pens for accelerated tissue recovery. Explore synergistic healing mechanisms, dosing schedules, and published study findings.
FAQEverything you need to know about peptide pen systems. Learn how pre-mixed peptide pens work, their advantages over vials, dosing mechanisms, and more.
CATEGORYResearch-grade recovery peptide pens. BPC-157 and TB-500 for tissue repair, wound healing, and inflammation research. >99% purity, UK delivery.
CATEGORYResearch-grade weight loss peptide pens. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Pre-mixed pens, >99% purity, next-day UK delivery.
Premium pre-mixed peptide pens with next-day UK delivery. GMP manufactured, >99% purity guaranteed.
SHOP ALL PEPTIDES
